120 related articles for article (PubMed ID: 19421149)
1. Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2.
Gammoh N; Isaacson E; Tomaić V; Jackson DJ; Doorbar J; Banks L
Oncogene; 2009 Jun; 28(23):2299-304. PubMed ID: 19421149
[TBL] [Abstract][Full Text] [Related]
2. Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.
Gammoh N; Grm HS; Massimi P; Banks L
J Virol; 2006 Feb; 80(4):1787-97. PubMed ID: 16439535
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner.
Hwang SG; Lee D; Kim J; Seo T; Choe J
J Biol Chem; 2002 Jan; 277(4):2923-30. PubMed ID: 11713253
[TBL] [Abstract][Full Text] [Related]
4. Estrogen contributes to non-pRb targeted HPV18 E7-caused cell proliferation and transformation.
Yan X; Shah W; Li X; Wang Y
Cancer Biol Ther; 2010 Feb; 9(3):206-15. PubMed ID: 20009582
[TBL] [Abstract][Full Text] [Related]
5. The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer.
Chen J; Deng Y; Ao L; Song Y; Xu Y; Wang CC; Choy KW; Tony Chung KH; Du Q; Sui Y; Yang T; Yang J; Li H; Zou C; Tang T
Cancer Lett; 2019 Sep; 460():75-85. PubMed ID: 31247272
[TBL] [Abstract][Full Text] [Related]
6. Type-specific interaction between human papillomavirus type 58 E2 protein and E7 protein inhibits E7-mediated oncogenicity.
Wang X; Qi M; Yu X; Yuan Y; Zhao W
J Gen Virol; 2012 Jul; 93(Pt 7):1563-1572. PubMed ID: 22442110
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.
Stirdivant SM; Huber HE; Patrick DR; Defeo-Jones D; McAvoy EM; Garsky VM; Oliff A; Heimbrook DC
Mol Cell Biol; 1992 May; 12(5):1905-14. PubMed ID: 1314947
[TBL] [Abstract][Full Text] [Related]
8. Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA.
Lee CJ; Suh EJ; Kang HT; Im JS; Um SJ; Park JS; Hwang ES
Exp Cell Res; 2002 Jul; 277(2):173-82. PubMed ID: 12083799
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members.
Duensing S; Münger K
J Virol; 2003 Nov; 77(22):12331-5. PubMed ID: 14581569
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis.
Shin MK; Balsitis S; Brake T; Lambert PF
Cancer Res; 2009 Jul; 69(14):5656-63. PubMed ID: 19584294
[TBL] [Abstract][Full Text] [Related]
11. SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein.
Kamio M; Yoshida T; Ogata H; Douchi T; Nagata Y; Inoue M; Hasegawa M; Yonemitsu Y; Yoshimura A
Oncogene; 2004 Apr; 23(17):3107-15. PubMed ID: 15021916
[TBL] [Abstract][Full Text] [Related]
12. P53 represses human papillomavirus type 16 DNA replication via the viral E2 protein.
Brown C; Kowalczyk AM; Taylor ER; Morgan IM; Gaston K
Virol J; 2008 Jan; 5():5. PubMed ID: 18190682
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.
Heck DV; Yee CL; Howley PM; Münger K
Proc Natl Acad Sci U S A; 1992 May; 89(10):4442-6. PubMed ID: 1316608
[TBL] [Abstract][Full Text] [Related]
14. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
16. Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts.
Defeo-Jones D; Vuocolo GA; Haskell KM; Hanobik MG; Kiefer DM; McAvoy EM; Ivey-Hoyle M; Brandsma JL; Oliff A; Jones RE
J Virol; 1993 Feb; 67(2):716-25. PubMed ID: 8380462
[TBL] [Abstract][Full Text] [Related]
17. Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle Arrest.
Giarrè M; Caldeira S; Malanchi I; Ciccolini F; Leão MJ; Tommasino M
J Virol; 2001 May; 75(10):4705-12. PubMed ID: 11312342
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product.
Haskell KM; Vuocolo GA; Defeo-Jones D; Jones RE; Ivey-Hoyle M
J Gen Virol; 1993 Jan; 74 ( Pt 1)():115-9. PubMed ID: 8380832
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
Massimi P; Pim D; Banks L
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2607-13. PubMed ID: 9349482
[TBL] [Abstract][Full Text] [Related]
20. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.
Gonzalez SL; Stremlau M; He X; Basile JR; Münger K
J Virol; 2001 Aug; 75(16):7583-91. PubMed ID: 11462030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
